ME Gore

Cisplatin/carboplatin cross-resistance in ovarian cancer

ME Gore, I Fryatt, E. Wiltshaw et al. · British Journal of Cancer · 1989 · 117 citations · Full text

Medicine, Gynecology, Cancer Treatment +4

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL-2) in patients with metastatic melanoma

SR Johnston, D CONSTENLA, J. Moore et al. · British Journal of Cancer · 1998 · 88 citations · Full text

Phase Ii Trial, Medicine, Melanoma +13

Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease

JL Mansi, CJ Gallagher, ME Gore et al. · British Journal of Cancer · 1994 · 72 citations · Full text

Epithelial Ovarian Cancer, Medicine, Oral Etoposide +8

Platinum-Taxol non-cross resistance in epithelial ovarian cancer

ME Gore, Nancy Preston, Roger A’Hern et al. · British Journal of Cancer · 1995 · 27 citations · Full text

Platinum-taxol Non-cross Resistance, Medicine, Gynecology +4

Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck

ME Gore, P. Riches, K.A. MacLennan et al. · British Journal of Cancer · 1992 · 12 citations · Full text

Inflammation, Tumor Biology, Squamous Cell Carcinoma +9